Teva Accuses Mylan, Others Of Infringing Copaxone Patent
Teva Pharmaceutical Industries Ltd. on Monday accused Dr. Reddy's, Mylan, Sandoz and several other drugmakers in Delaware federal court of infringing one of its newer patents for the multiple sclerosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article